SPP1 and astrocytoma (excluding glioblastoma): Overall, the seven TAM populations were observed to be contributing in an increased capacity to pathways such as SPP1, COMPLEMENT, GALECTIN and PTN compared to their counterparts in IDH-mutant astrocytoma.